… among patients … of ventricular arrhythmias with sacubitril/valsartan treatment. Compared
to Wang et al. and Mujadzic et al., we specifically focused our topic in chronic HFrEF patients. …

… Chi-square test is used to compare two groups on a categorical scale and determine the …
and outcomes after myocardial infarction: Insights from the valsartan in acute myocardial …

… On the basis of the established safety profile of empagliflozin, EMPACT-MI used a … of a
possible treatment effect of sacubitril with valsartan on the … Post-myocardial infarction heart failure …

… Valsartan (Val) is angiotensin II receptor blocker used in the treatment of congestive heart
failure, high blood pressure and post-myocardial infarction [1-4]. Val acts on receptor subtype …

… of hospital admissions in patients with heart failure by the use of valsartan compared to ACE
… mortality among patients with post myocardial infarction with left ventricular dysfunction by …

… in reducing heart failure Events after Myocardial Infarction) trial … that the treatment effects of
sacubitril/valsartan vs ramipril … routine use of sacubitril/valsartan over ramipril in patients with …

… factors and improved post myocardial infarction (MI) survival. … /valsartan could be used at
an earlier time in HFrEF patients … treatment by sacubitril/valsartan in patients with heart failure …

… assessment of cardiac remodeling post-myocardial infarction, as … in patients with cardiovascular
disease, patients should be … sacubitril/valsartan did not reduce cardiovascular death or …

… heart failure specialist and interventional cardiology. … He has history of medication non-adherence
and has not used … ), beta blockers, sacubitril-valsartan, nitrates, and diuretics and …

… heart failure event was defined as inpatient hospitalization with a diagnosis of heart failure …
in this study can be used as a screening tool to identify patients with the highest risk who may …